• Adjusted EBITDAaL: €13.0–€13.3 billion
• Adjusted free cash flow: €2.6–€2.9 billion

This powerful combination of a quarterly beat and a significantly upgraded outlook sent Vodafone shares surging 4.67% on Monday . Both Bloomberg and Reuters cited Vodafone's Q1 beat and upgraded outlook as a major stock mover on the day .

2. AstraZeneca: Profit Beat and a Reaffirmed $80 Billion Ambition

AstraZeneca reported its H1 and Q2 2026 results, which comfortably beat profit expectations. Key figures from the report include:

• Q2 net profit: $2.51 billion, up ~2%, driven by blockbuster cancer drug sales
• Adjusted EPS (Q2): $2.63, above the consensus estimate of $2.48
• H1 total revenue: Rose 9% at actual exchange rates (6% at constant currency) to $30.67 billion

Crucially, the company reaffirmed its long-term ambition to reach $80 billion in total revenue by 2030, a goal supported by its strong pipeline in oncology, rare disease, and weight-loss treatments . The results were well-received, with AstraZeneca shares edging modestly higher on Monday following the release .

3. The Broad Macro Catalyst: US-Iran Ceasefire Pause and Oil Price Drop

While Vodafone and AstraZeneca drove stock-specific gains, the broader European rally was fueled by a significant macro event. Over the weekend, the US paused its air campaign against Iran for a second consecutive night, and Iran refrained from further strikes, triggering a powerful risk-on rally across equity markets . A senior Iranian official told Reuters that Iran would halt attacks if the US did the same .

This geopolitical de-escalation had an immediate and dramatic effect on oil prices:

• The pan-European STOXX 600 climbed nearly 1%
• The FTSE 100 rose ~0.5% to its highest level since early March
• Brent crude fell more than 5% to around $91.80/barrel, relieving inflationary pressure and boosting sentiment across the board

Key US Events Markets Are Watching Next This Week

With Monday's rally behind them, markets are now laser-focused on a dense US calendar, where four "Magnificent Seven" earnings reports and a Federal Reserve interest rate decision are all compressed into the same week .

Big Tech Earnings (This Week)

The results from four of the world's largest tech companies are expected to be the dominant market driver for the rest of the week, coming on the heels of Alphabet's disappointing report . Investors are expected to scrutinize AI-related capital expenditure, cloud revenue growth, and overall margin resilience .

Federal Reserve Interest Rate Decision

The Federal Open Market Committee (FOMC) is set to announce its latest monetary policy decision, which will be a major focus for global markets.

• FOMC Decision: Wednesday, July 29
• Press Conference: Thursday, July 30
• Consensus: The Fed is widely expected to hold rates steady in the 3.50%–3.75% range
• Uncertainty Remains: While a hold is the baseline expectation, some uncertainty persists. As of July 23, interest rate futures showed the probability of a 25-basis-point rate hike being priced in by some traders, which had risen to approximately 31.5% from 12.8% a week earlier .

Ongoing Risks: Oil and US Tariffs

Despite the relief rally, significant risks remain on the horizon that could alter the market's trajectory.

• Oil Prices: While Brent crude fell sharply on Monday, it remains elevated at around $91.80/barrel . Any resumption of US-Iran hostilities could spike prices again, reintroducing inflationary pressure .
• US Tariffs: The broader macro backdrop includes ongoing uncertainty around US tariff policy. This remains a persistent headwind for global trade sentiment and corporate outlooks, though it was not the primary market driver on Monday .

In short, Monday's European rally was a powerful "double boost"—strong company results from Vodafone and AstraZeneca layered on top of a geopolitical relief rally driven by falling oil prices. However, the market's attention has already pivoted to what matters most for the rest of the week: the outcome of the Fed's policy meeting and the next wave of earnings from Big Tech.

• Adjusted EBITDAaL: €13.0–€13.3 billion
• Adjusted free cash flow: €2.6–€2.9 billion

This powerful combination of a quarterly beat and a significantly upgraded outlook sent Vodafone shares surging 4.67% on Monday . Both Bloomberg and Reuters cited Vodafone's Q1 beat and upgraded outlook as a major stock mover on the day .

2. AstraZeneca: Profit Beat and a Reaffirmed $80 Billion Ambition

AstraZeneca reported its H1 and Q2 2026 results, which comfortably beat profit expectations. Key figures from the report include:

• Q2 net profit: $2.51 billion, up ~2%, driven by blockbuster cancer drug sales
• Adjusted EPS (Q2): $2.63, above the consensus estimate of $2.48
• H1 total revenue: Rose 9% at actual exchange rates (6% at constant currency) to $30.67 billion

Crucially, the company reaffirmed its long-term ambition to reach $80 billion in total revenue by 2030, a goal supported by its strong pipeline in oncology, rare disease, and weight-loss treatments . The results were well-received, with AstraZeneca shares edging modestly higher on Monday following the release .

3. The Broad Macro Catalyst: US-Iran Ceasefire Pause and Oil Price Drop

While Vodafone and AstraZeneca drove stock-specific gains, the broader European rally was fueled by a significant macro event. Over the weekend, the US paused its air campaign against Iran for a second consecutive night, and Iran refrained from further strikes, triggering a powerful risk-on rally across equity markets . A senior Iranian official told Reuters that Iran would halt attacks if the US did the same .

This geopolitical de-escalation had an immediate and dramatic effect on oil prices:

• The pan-European STOXX 600 climbed nearly 1%
• The FTSE 100 rose ~0.5% to its highest level since early March
• Brent crude fell more than 5% to around $91.80/barrel, relieving inflationary pressure and boosting sentiment across the board

Key US Events Markets Are Watching Next This Week

With Monday's rally behind them, markets are now laser-focused on a dense US calendar, where four "Magnificent Seven" earnings reports and a Federal Reserve interest rate decision are all compressed into the same week .

Big Tech Earnings (This Week)

The results from four of the world's largest tech companies are expected to be the dominant market driver for the rest of the week, coming on the heels of Alphabet's disappointing report . Investors are expected to scrutinize AI-related capital expenditure, cloud revenue growth, and overall margin resilience .

Federal Reserve Interest Rate Decision

The Federal Open Market Committee (FOMC) is set to announce its latest monetary policy decision, which will be a major focus for global markets.

• FOMC Decision: Wednesday, July 29
• Press Conference: Thursday, July 30
• Consensus: The Fed is widely expected to hold rates steady in the 3.50%–3.75% range
• Uncertainty Remains: While a hold is the baseline expectation, some uncertainty persists. As of July 23, interest rate futures showed the probability of a 25-basis-point rate hike being priced in by some traders, which had risen to approximately 31.5% from 12.8% a week earlier .

Ongoing Risks: Oil and US Tariffs

Despite the relief rally, significant risks remain on the horizon that could alter the market's trajectory.

• Oil Prices: While Brent crude fell sharply on Monday, it remains elevated at around $91.80/barrel . Any resumption of US-Iran hostilities could spike prices again, reintroducing inflationary pressure .
• US Tariffs: The broader macro backdrop includes ongoing uncertainty around US tariff policy. This remains a persistent headwind for global trade sentiment and corporate outlooks, though it was not the primary market driver on Monday .

In short, Monday's European rally was a powerful "double boost"—strong company results from Vodafone and AstraZeneca layered on top of a geopolitical relief rally driven by falling oil prices. However, the market's attention has already pivoted to what matters most for the rest of the week: the outcome of the Fed's policy meeting and the next wave of earnings from Big Tech.